The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Association of time to second-line (2L) immune-checkpoint inhibitors (ICI) and outcomes with ICIs in patients (pts) with advanced urothelial carcinoma (aUC).
 
Dimitrios Makrakis
Travel, Accommodations, Expenses - GlaxoSmithKline
 
Rafee Talukder
No Relationships to Disclose
 
Scott Dawsey
No Relationships to Disclose
 
Lucia Carril
No Relationships to Disclose
 
Tyler F. Stewart
Consulting or Advisory Role - Seattle Genetics/Astellas
Research Funding - GRAIL
 
Rafael Morales-Barrera
Consulting or Advisory Role - AstraZeneca; MSD; Sanofi
Speakers' Bureau - Asofarma; MSD Oncology
Travel, Accommodations, Expenses - Astellas Pharma; AstraZeneca; Bayer; Clovis Oncology; Johnson & Johnson; Lilly; MSD; Pfizer; Roche/Genentech; Sanofi
 
Joseph J. Park
No Relationships to Disclose
 
Claudia Angela Maria Fulgenzi
No Relationships to Disclose
 
Jure Murgic
Honoraria - Astellas Pharma; Roche
Consulting or Advisory Role - Bristol-Myers Squibb; Sandoz
Research Funding - Astellas Pharma
Travel, Accommodations, Expenses - BMS; Janssen; Roche
 
Naomi Vather-Wu
No Relationships to Disclose
 
Ivan de Kouchkovsky
No Relationships to Disclose
 
Michael Edward Devitt
Consulting or Advisory Role - Astellas Pharma; Seagen
Research Funding - Kangpu Biopharmaceuticals (Inst); Seagen (Inst); Syneos Health (Inst); Veru (Inst)
 
Giuseppe Di Lorenzo
Consulting or Advisory Role - Astellas Amgen BioPharama; Janssen; Pfizer
 
Kavita Gupta
No Relationships to Disclose
 
Nishita Tripathi
No Relationships to Disclose
 
Roubini Zakopoulou
No Relationships to Disclose
 
Abhishek Tripathi
Consulting or Advisory Role - EMD Serono; Exelixis; Foundation Medicine; Genzyme; Pfizer
Research Funding - Aravive (Inst); Bayer (Inst); Bayer (Inst); Clovis Oncology (Inst); Corvus Pharmaceuticals (Inst); EMD Serono (Inst); Exact Sciences (Inst); Pfizer (Inst); WindMIL (Inst)
 
Eric Lu
No Relationships to Disclose
 
Petros Grivas
Consulting or Advisory Role - 4D Pharma; Astellas Pharma; AstraZeneca; Bristol-Myers Squibb; Dyania Health; EMD Serono; Exelixis; Genentech; GlaxoSmithKline; Guardant Health; Immunomedics; Infinity Pharmaceuticals; Janssen; Merck; Mirati Therapeutics; Pfizer; QED Therapeutics; Regeneron; Roche; Seagen
Research Funding - Bavarian Nordic (Inst); Bristol-Myers Squibb (Inst); Clovis Oncology (Inst); Debiopharm Group (Inst); EMD Serono (Inst); GlaxoSmithKline (Inst); Immunomedics (Inst); Kure It Cancer Research (Inst); Merck (Inst); Mirati Therapeutics (Inst); Pfizer (Inst); QED Therapeutics (Inst)
 
Ali Raza Khaki
Stock and Other Ownership Interests - Merck; Sanofi